Thryv Therapeutics Inc. Email Format
Biotechnology ResearchQuebec, Canada11-50 Employees
Thryv Therapeutics Inc. is a privately owned company based in Montreal, Quebec, Canada. Thryv Therapeutics is pioneering a precision medicine approach to treat Long QT Syndrome, heart failure, and atrial fibrillation with potent and selective inhibitors of Serum Glucocorticoid inducible Kinase. For more information, please visit www.thryvtrx.com.